New data with Takeda’s TYK2 inhibitor zasocitinib suggest it is significantly more effective than BMS’s Sotyktu in the treatment of psoriasis.
UK offers meningitis jab to young people after outbreak
The UK government has responded to calls to broaden vaccinations for meningitis B, offering the jab to “thousands” of young people this summer.
